2024-06-03T17:26:37-04:00 2023-12-31 461041593 FINANCIAL SOLUTION ADVISORS PLLC 4350 PABLO PROFESSIONAL CT STE 200 JACKSONVILLE FL 322243224 990 2023-01-01 341710663 CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION CLEV 2167913800 10701 EAST BOULEVARD CLEVELAND OH 44106 YNGVE FALCK-YTTER MD TREASURER 2167912300 2024-05-31 true YNGVE FALCK YTTER 999009999 true MICHAEL B MCLEOD CPA P00966646 9042962024 2024-06-03 2023 2023-04-26 12:10:37Z JILL K D MELLON JD MBA FACH 10701 EAST BLVD CLEVELAND OH 44106 4390885 false X N/A X 1991 OH THE PRIMARY TAX-EXEMPT PURPOSE OF THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION, A 501(C)(3) MEDICAL RESEARCH FOUNDATION ESTABLISHED IN ACCORDANCE WITH TITLE 38, SUBCHAPTER IV-RESEARCH AND EDUCATION CORPORATIONS, SECTIONS 7361-7368, IS TO SUPPORT BIOMEDICAL RESEARCH AT THE LOUIS STOKES CLEVELAND VA MEDICAL CENTER. 7 2 56 0 78 51324 3823426 4276657 12715 62904 0 3836219 4390885 0 0 2692038 2771009 0 0 2313462 2061217 5005500 4832226 -1169281 -441341 4723141 3996568 1047072 761571 3676069 3234997 X THE PRIMARY TAX-EXEMPT PURPOSE OF THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION, A 501(C)(3) MEDICAL RESEARCH FOUNDATION ESTABLISHED IN ACCORDANCE WITH TITLE 38, SUBCHAPTER IV-RESEARCH AND EDUCATION CORPORATIONS, SECTIONS 7361-7368, IS TO SUPPORT BIOMEDICAL AND CLINICAL RESEARCH AS WELL AS TO PROVIDE HEALTH-RELATED EDUCATIONAL ACTIVITIES IN CONJUNCTION WITH THE LOUIS STOKES CLEVELAND DEPARTMENT OF VA MEDICAL CENTER (VAMC). RESEARCH SPONSORED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION BENEFITS VETERANS TREATED AT THE LOUIS STOCKS CLEVELAND VAMC AND THE GENERAL PUBLIC BY ADVANCING KNOWLEDGE IN THE DIAGNOSIS AND TREATMENT OF DISEASE AND DISABILITY. EDUCATION PROGRAMS SUPPORTED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION HELP DISSEMINATE THE RESULTS OF RESEARCH SO THEY MAY BE TRANSLATED TO CLINICAL PRACTICE, PROVIDE HOSPITAL STAFF WITH TRAINING IN THE LATEST TREATMENTS, AND HELP PATIENTS UNDERSTAND AND MANAGE THEIR MEDICAL CONDITIONS. false false 240926 DR. KATARINA GREER, DOD AWARD NONENDOSCOPIC SCREENING TO IMPACT ESOPHAGEAL CANCER IN VETERANS ESOPHAGEAL ADENOCARCINOMA (EAC) HAS INCREASED MORE THAN 6-FOLD IN THE PAST FOUR DECADES. THE INCORPORATION OF A NON-ENDOSCOPIC DETECTION METHOD IN PRIMARY CARE PRACTICE WILL INCREASE THE POSITIVE PREDICTIVE VALUE OF EGD AND INCREASE THE DETECTION OF BARRETT'S ESOPHAGUS (BE). THIS STUDY WILL AIM TO DETERMINE SENSITIVITY, SPECIFICITY, AND POSITIVE PREDICTIVE VALUE OF ESOCHECK SAMPLING DEVICE ESOGUARD (DNA MARKER PANEL LABORATORY DIAGNOSTIC TEST) PERFORMED IN ROUTINE PRACTICE FOR DETECTING BE IN AN AT-RISK POPULATION. THE SECOND AIM OF THE STUDY IS TO COMPARE THE YIELD OF DETECTED BE USING AN ESOCHECK/ESOGUARD STRATEGY VERSUS STANDARD EGD ALONE STRATEGY IN ROUTINE PRACTICE IN AT-RISK POPULATIONS AT THE CLEVELAND VA. THE EXPECTED OUTCOME OF THE PROPOSED WORK IS THE GATHERING OF DETAILED INFORMATION ABOUT THE TEST PERFORMANCE CHARACTERISTICS, I.E., SENSITIVITY, SPECIFICITY, POSITIVE AND NEGATIVE PREDICTIVE VALUE. SHOULD THE SCREENING TEST PERFORM WELL, ESOCHECK/ESOGUARD TEST WOULD BE PRODUCED ON A LARGER SCALE, ITS MOLECULAR DIAGNOSTICS PROCESS WOULD BE AUTOMATED, DRIVING COSTS OF THE SCREENING DEVICE DOWN. TEST INDICATION COULD BE EXPANDED TO ALL OBESE PATIENTS OLDER THAN 50 WITHOUT A HISTORY OF CHRONIC GERD, EXPLORING THE PREVALENCE OF BE/ECA IN ASYMPTOMATIC INDIVIDUALS. 40070 DR. ELIAS VEIZI, NIH SUBAWARD A SEQUENCED-STRATEGY FOR IMPROVING OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS PAIN" SKOAP STUDY. SKOAP IS A NATIONAL STUDY FUNDED BY THE HELPING ADDICTION LONG-TERM INITIATIVE OR NIH HEAL INITIATIVE. THE PURPOSE OF THE SKOAP STUDY IS TO COMPARE DIFFERENT TREATMENT OPTIONS FOR PEOPLE LIVING WITH KNEE OSTEOARTHRITIS PAIN. THE GOAL IS TO REDUCE PAIN AND IMPROVE FUNCTION USING CONSERVATIVE TREATMENT AND IF NEEDED, NON-SURGICAL PROCEDURAL TREATMENTS. THERE IS AN URGENT PUBLIC HEALTH NEED TO FIND CLINICALLY PROVEN TREATMENTS TO IMPROVE QUALITY OF LIFE AND REDUCE RELIANCE ON OPIOIDS, FOR LONG-TERM PAIN MANAGEMENT FOR PATIENTS SUFFERING FROM KNEE OA. THIS EFFECTIVENESS TRIAL WILL COMPARE AVAILABLE TREATMENTS FOR PAIN REDUCTION AND FUNCTIONAL IMPROVEMENT IN PATIENTS WITH KNEE OSTEOARTHRITIS. THE RESULTS CAN LEAD TO IMPROVED PATIENT SELECTION AND INFORM EVIDENCE-BASED GUIDANCE BY OFFERING WELL-TESTED, EFFECTIVE, NON-OPIOID ALTERNATIVES. 38016 DR. RON TRIOLO, PARALYZED VETERANS OF AMERICA AWARD, ADAPTED VIRTUAL REALITY GAMES TO IMPROVE ENGAGEMENT DURING STIMULATION- DRIVEN EXERCISE THE OVERALL GOAL OF THIS PROJECT IS TO DEVELOP EFFECTIVE IMMERSIVE VR GAMES TAILORED TO THE ABILITIES OF VETERANS WITH PARALYSIS TO IMPROVE STIMULATION-INDUCED EXERCISE EXPERIENCE AND PERFORMANCE. THIS WILL BE DIVIDED INTO TWO OBJECTIVES AND ANTICIPATED OUTCOMES: OBJECTIVE 1: DEVELOP IMMERSIVE VR GAMES THAT INCREASE USER ENGAGEMENT AND ACTIVE INPUT DURING STIMULATION-INDUCED CYCLING AND ROWING EXERCISES. OBJECTIVE 2: ASSESS THE EFFICACY OF THE DEVELOPED VR GAMES IN TERMS OF PHYSIOLOGICAL RESPONSE, FUNCTIONAL EXERCISE OUTPUT, AND PARTICIPANT RATINGS OF ENGAGEMENT 3633429 OTHER RESEARCH AND SERVICE ACTIVITIES. 3633429 3952441 true false false false false false false false false false false false false false false true true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false true 4 0 56 true false false false false false false false false false false false false false false X 7 2 false false false false false false false true true false false true true true true true false true false false OH X JEFF MOORE PHD 2167913800 10701 EAST BLVD CLEVELAND OH 44106 BRIGID WILSON PHD HCE 40.00 X 127386 0 36820 JEFF MOORE PHD EXECUTIVE DI 40.00 X 126437 0 12658 RICHARD DECHANT TRUSTEE/DIRE 1.00 X 0 0 0 JILL K D MELLON JD MBA FACH PRESIDENT 1.00 X X 0 0 0 GEORGE JASKIW MD SECRETARY 1.00 X X 0 0 0 MURRAY ALTOSE MD TRUSTEE/DIRE 1.00 X 0 0 0 SIMRAN SINGH MD TRUSTEE/DIRE 1.00 X 0 0 0 YNGVE FALCK-YTTER MD TREASURER 1.00 X X 0 0 0 NEAL PEACHEY PHD VICE PRESIDE 1.00 X X 0 0 0 253823 49478 2 false true false 51324 51324 FEDERAL CONT & GRANT REV 541700 2318591 2318591 NON-FEDERAL CONT & GRANT REV 541700 1494880 1494880 IPA REVENUE 541700 463186 463186 4276657 62904 62904 4390885 4339561 X 126437 126437 2118385 1605969 512416 60922 37738 23184 284104 208115 75989 181161 130158 51003 2025 2025 19799 19799 1353971 1313965 40006 10682 7933 2749 26182 16289 9893 74076 74076 81494 78253 3241 5959 5959 RESEARCH STUDY COSTS 291812 291812 EQUIPMENT & REPAIRS 86481 86481 STUDY ADJUSTMENTS 49911 49911 SUBJECT PAYMENTS 43478 43478 15347 8263 7084 4832226 3952441 879785 0 1207159 373877 997899 1250196 2501011 2369212 17072 3283 4723141 3996568 844079 672089 202993 89482 1047072 761571 X 3676069 3234997 3676069 3234997 4723141 3996568 -441341 269 X false true X false true true X CLEVELAND VA MEDICAL CENTER CLEVELAND OH X 4391154 269 269 4390885 4390885 4832226 4832226 4832226 SCHEDULE D, PAGE 3, PART X THE FOUNDATION QUALIFIES AS A TAX-EXEMPT ORGANIZATION UNDER SECTION 501(C) (3) OF THE INTERNAL REVENUE CODE (IRC). THE FOUNDATION PERIODICALLY ASSESSES WHETHER IT HAS INCURRED INCOME TAX EXPENSE OR RELATED INTEREST OR PENALTIES IN ACCORDANCE WITH ACCOUNTING FOR UNCERTAIN TAX POSITIONS. NO SUCH AMOUNTS WERE RECOGNIZED FOR THE YEARS ENDING DECEMBER 31, 2023 AND 2022, RESPECTIVELY. SHOULD THE FOUNDATIONS TAX-EXEMPT STATUS BE CHALLENGED IN THE FUTURE, THE FOUNDATIONS 2021, 2022, AND 2023 TAX YEARS ARE OPEN FOR EXAMINATION BY THE IRS. false false false false false false false false false BRIGID WILSON PHD HCE 127386 36820 164206 FORM 990 - ORGANIZATION'S MISSION THE PRIMARY TAX-EXEMPT PURPOSE OF THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION, A 501(C)(3) MEDICAL RESEARCH FOUNDATION ESTABLISHED IN ACCORDANCE WITH TITLE 38, SUBCHAPTER IV-RESEARCH AND EDUCATION CORPORATIONS, SECTIONS 7361-7368, IS TO SUPPORT BIOMEDICAL AND CLINICAL RESEARCH AS WELL AS TO PROVIDE HEALTH-RELATED EDUCATIONAL ACTIVITIES IN CONJUNCTION WITH THE LOUIS STOKES CLEVELAND DEPARTMENT OF VA MEDICAL CENTER (VAMC). RESEARCH SPONSORED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION BENEFITS VETERANS TREATED AT THE LOUIS STOCKS CLEVELAND VAMC AND THE GENERAL PUBLIC BY ADVANCING KNOWLEDGE IN THE DIAGNOSIS AND TREATMENT OF DISEASE AND DISABILITY. EDUCATION PROGRAMS SUPPORTED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION HELP DISSEMINATE THE RESULTS OF RESEARCH SO THEY MAY BE TRANSLATED TO CLINICAL PRACTICE, PROVIDE HOSPITAL STAFF WITH TRAINING IN THE LATEST TREATMENTS, AND HELP PATIENTS UNDERSTAND AND MANAGE THEIR MEDICAL CONDITIONS. FORM 990, PAGE 2, PART III, LINE 4A DR. KATARINA GREER, DOD AWARD NONENDOSCOPIC SCREENING TO IMPACT ESOPHAGEAL CANCER IN VETERANS ESOPHAGEAL ADENOCARCINOMA (EAC) HAS INCREASED MORE THAN 6-FOLD IN THE PAST FOUR DECADES. THE INCORPORATION OF A NON-ENDOSCOPIC DETECTION METHOD IN PRIMARY CARE PRACTICE WILL INCREASE THE POSITIVE PREDICTIVE VALUE OF EGD AND INCREASE THE DETECTION OF BARRETT'S ESOPHAGUS (BE). THIS STUDY WILL AIM TO DETERMINE SENSITIVITY, SPECIFICITY, AND POSITIVE PREDICTIVE VALUE OF ESOCHECK SAMPLING DEVICE ESOGUARD (DNA MARKER PANEL LABORATORY DIAGNOSTIC TEST) PERFORMED IN ROUTINE PRACTICE FOR DETECTING BE IN AN AT-RISK POPULATION. THE SECOND AIM OF THE STUDY IS TO COMPARE THE YIELD OF DETECTED BE USING AN ESOCHECK/ESOGUARD STRATEGY VERSUS STANDARD EGD ALONE STRATEGY IN ROUTINE PRACTICE IN AT-RISK POPULATIONS AT THE CLEVELAND VA. THE EXPECTED OUTCOME OF THE PROPOSED WORK IS THE GATHERING OF DETAILED INFORMATION ABOUT THE TEST PERFORMANCE CHARACTERISTICS, I.E., SENSITIVITY, SPECIFICITY, POSITIVE AND NEGATIVE PREDICTIVE VALUE. SHOULD THE SCREENING TEST PERFORM WELL, ESOCHECK/ESOGUARD TEST WOULD BE PRODUCED ON A LARGER SCALE, ITS MOLECULAR DIAGNOSTICS PROCESS WOULD BE AUTOMATED, DRIVING COSTS OF THE SCREENING DEVICE DOWN. TEST INDICATION COULD BE EXPANDED TO ALL OBESE PATIENTS OLDER THAN 50 WITHOUT A HISTORY OF CHRONIC GERD, EXPLORING THE PREVALENCE OF BE/ECA IN ASYMPTOMATIC INDIVIDUALS. FORM 990, PAGE 2, PART III, LINE 4B DR. ELIAS VEIZI, NIH SUBAWARD A SEQUENCED-STRATEGY FOR IMPROVING OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS PAIN" SKOAP STUDY. SKOAP IS A NATIONAL STUDY FUNDED BY THE HELPING ADDICTION LONG-TERM INITIATIVE OR NIH HEAL INITIATIVE. THE PURPOSE OF THE SKOAP STUDY IS TO COMPARE DIFFERENT TREATMENT OPTIONS FOR PEOPLE LIVING WITH KNEE OSTEOARTHRITIS PAIN. THE GOAL IS TO REDUCE PAIN AND IMPROVE FUNCTION USING CONSERVATIVE TREATMENT AND IF NEEDED, NON-SURGICAL PROCEDURAL TREATMENTS. THERE IS AN URGENT PUBLIC HEALTH NEED TO FIND CLINICALLY PROVEN TREATMENTS TO IMPROVE QUALITY OF LIFE AND REDUCE RELIANCE ON OPIOIDS, FOR LONG-TERM PAIN MANAGEMENT FOR PATIENTS SUFFERING FROM KNEE OA. THIS EFFECTIVENESS TRIAL WILL COMPARE AVAILABLE TREATMENTS FOR PAIN REDUCTION AND FUNCTIONAL IMPROVEMENT IN PATIENTS WITH KNEE OSTEOARTHRITIS. THE RESULTS CAN LEAD TO IMPROVED PATIENT SELECTION AND INFORM EVIDENCE-BASED GUIDANCE BY OFFERING WELL-TESTED, EFFECTIVE, NON-OPIOID ALTERNATIVES. FORM 990, PAGE 2, PART III, LINE 4C DR. RON TRIOLO, PARALYZED VETERANS OF AMERICA AWARD, ADAPTED VIRTUAL REALITY GAMES TO IMPROVE ENGAGEMENT DURING STIMULATION- DRIVEN EXERCISE THE OVERALL GOAL OF THIS PROJECT IS TO DEVELOP EFFECTIVE IMMERSIVE VR GAMES TAILORED TO THE ABILITIES OF VETERANS WITH PARALYSIS TO IMPROVE STIMULATION-INDUCED EXERCISE EXPERIENCE AND PERFORMANCE. THIS WILL BE DIVIDED INTO TWO OBJECTIVES AND ANTICIPATED OUTCOMES: OBJECTIVE 1: DEVELOP IMMERSIVE VR GAMES THAT INCREASE USER ENGAGEMENT AND ACTIVE INPUT DURING STIMULATION-INDUCED CYCLING AND ROWING EXERCISES. OBJECTIVE 2: ASSESS THE EFFICACY OF THE DEVELOPED VR GAMES IN TERMS OF PHYSIOLOGICAL RESPONSE, FUNCTIONAL EXERCISE OUTPUT, AND PARTICIPANT RATINGS OF ENGAGEMENT FORM 990, PAGE 2, PART III, LINE 4D OTHER RESEARCH AND SERVICE ACTIVITIES. FORM 990, PAGE 6, PART VI, LINE 11B FORM 990 IS DISTRIBUTED TO THE BOARD OF DIRECTORS AND IS REVIEWED, DISCUSSED, AND APPROVED. FORM 990, PAGE 6, PART VI, LINE 12C THE ORGANIZATION IS REQUIRED BY THE U.S. DEPARTMENT OF VETERANS AFFAIRS TO MONITOR ITS CONFLICT OF INTEREST POLICY THROUGH ANNUAL CONFLICT OF INTEREST AND ETHICS CERTIFICATIONS. FORM 990, PAGE 6, PART VI, LINE 15A THE ORGANIZATION HAS ONLY ONE COMPENSATED OFFICER, THE EXECUTIVE DIRECTOR. AN ANNUAL REVIEW OF ALL COMPENSATION FOR EMPLOYEES IS PERFORMED BY THE BOARD OF DIRECTORS. THE AMOUNT OF THE EXECUTIVE DIRECTOR'S SALARY THUS CALCULATED IS INCLUDED IN THE BUDGET WHICH IS APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PAGE 6, PART VI, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE FOR INSPECTION UPON WRITTEN REQUEST. THE ORGANIZATION DOES NOT GENERALLY MAKE ITS ORGANIZING DOCUMENTS OR CONFLICT OF INTEREST POLICY AVAILABLE TO THE GENERAL PUBLIC. FORM 990, PART IX, LINE 11G PAYROLL PROCESSING FEES 0 9,195 0 CONSULTING FEES 0 29,687 0 RETIREMENT PROFESSIONAL FEES 0 1,124 0 OUTSIDE STUDY FEES 1,313,965 0 0 TOTAL 1,313,965 40,006 0